Data streaming is an increasingly important capability for businesses. Confluent is the leader in the industry, yet it has only scratched the surface of its opportunity.
Confluent delivered better-than-expected fourth-quarter results, which sent its shares flying. The company's massive addressable market should help it sustain solid growth going forward.
Here is how Confluent (CFLT) and Elastic (ESTC) have performed compared to their sector so far this year.

Why Confluent Stock Is Skyrocketing This Week

10:09am, Friday, 09'th Feb 2024
Confluent's fourth-quarter earnings report came in far better than expected this week. The company's Q4 sales and profits beat Wall Street's targets.

Why Confluent Stock Blasted Higher on Thursday

12:15pm, Thursday, 08'th Feb 2024
Confluent's financial results were much better than many had feared. The company's guidance for the coming year also came in above expectations, giving the stock a boost.
While the top- and bottom-line numbers for Confluent (CFLT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics comp
Confluent, Inc. (CFLT) Q4 2023 Earnings Call Transcript
Shares of Confluent CFLT, +3.45% rose late Wednesday after the data-streaming company forecast more than 20% revenue growth in 2024 and its first breakeven year based on certain metrics.
Confluent's (CFLT) fourth-quarter 2023 earnings and revenues are likely to increase year over year.
Get a deeper insight into the potential performance of Confluent (CFLT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for
Pfizer's post-COVID hangover has created a temporary soft spot in its longer-term stock trajectory. Confluent's growth remains solid, even as its stock price has suffered.
Confluent (CFLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Among 2023 IPOs, one of the top performers was RayzeBio Inc. NASDAQ: RYZB, a biotech that's out of play now because it's being acquired by Bristol Myers Squibb Co. NYSE: BMY.
The U.S. market for initial public offerings is expected to stage a recovery in 2024 from the drought of the last two years, buoyed by expectations the Federal Reserve will switch to a rate-cutting cy
Confluent is scratching the surface of a massive market opportunity, which should allow it to sustain healthy long-term growth. ASML Holding is playing a central role in the semiconductor industry's g
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE